Loading…

TRPV4 couples with NCX1 to mediate glucose‐dependent glucagon‐like peptide‐1 release and improve glucose homeostasis

Although glucose, as a secretagogue of intestinal hormone, can stimulate glucagon‐like peptide 1 (GLP‐1) release, it has not been fully elucidated how glucose triggers GLP‐1 release from enteroendocrine cells (EECs). Here, we investigated the regulatory mechanisms of glucose‐induced Ca2+‐dependent G...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of physiology 2024-11, Vol.602 (24), p.6827-6847
Main Authors: Chen, Xiongying, Chu, Fenglan, Sunchen, Sijin, Li, Junhui, Zhang, Mengting, Xu, Feng, Dong, Hui
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although glucose, as a secretagogue of intestinal hormone, can stimulate glucagon‐like peptide 1 (GLP‐1) release, it has not been fully elucidated how glucose triggers GLP‐1 release from enteroendocrine cells (EECs). Here, we investigated the regulatory mechanisms of glucose‐induced Ca2+‐dependent GLP‐1 release from EECs. STC‐1 cells that possess many features of native intestinal EECs were used. The expression of TRPV4 channels and Na+/Ca2+ exchanger 1 (NCX1) in STC‐1 was analysed by immunocytochemistry. Calcium and sodium imaging, and patch clamp were applied, and GLP‐1 was detected using quantitative PCR, western blot and enzyme‐linked immunosorbent assays. Glucose markedly induced Na+ and Ca2+ signalling in STC‐1 cells. The glucose‐induced Ca2+ signalling was significantly attenuated by selective blockers of the voltage‐gated Ca2+ channels (VGCC), ryanodine receptors and InsP3 receptors. Most importantly, glucose‐induced Ca2+ signalling was significantly attenuated by the selective blockers of TRPV4 and NCX1. Moreover, the physical and functional couplings of TRPV4 and NCX1 were demonstrated in STC‐1 cells, and they promoted glucose‐mediated Ca2+ signalling to upregulate expression and release of GLP‐1 via Ca2+‐sensitive PKCα. Finally, the selective TRPV4 activator improved glucose tolerance in an oral glucose tolerance test in mice, but the selective blockers of TRPV4 and NCX1 attenuated glucose‐induced intestinal GLP‐1 release. We demonstrate a coupling of TRPV4 and NCX1 in EECs to regulate glucose‐stimulated intestinal GLP‐1 release via a novel TRPV4/NCX1/Ca2+/PKCα axis. Targeting this axis may provide new therapeutic potentials for glycometabolic diseases. Key points Glucagon‐like peptide 1 (GLP‐1) secreted primarily from intestinal L cells in response to meals plays a critical role in maintaining glucose homeostasis. Physical and functional couplings of TRPV4 and NCX1 are pivotal in glucose‐stimulated GLP‐1 release via a novel TRPV4/NCX1/Ca2+/PKCα axis. Since this axis is involved in glucose homeostasis, our findings may provide new potential drug targets for prevention/treatment of glycometabolic diseases. figure legend TRPV4 coupled with NCX1 triggers glucose‐induced GLP‐1 release and mediates glucose homeostasis. Glucose via SGLT1 induces downstream effects, leading to Ca2+ influx via VGCC. VGCC induces TRPV4 activation to trigger major Ca2+ and Na+ influx. Na+ influx further induces Ca2+ influx via the Ca2+ entry mode of NCX1. Ca2+ entry activ
ISSN:0022-3751
1469-7793
1469-7793
DOI:10.1113/JP287092